An Analysis of Immune Checkpoint Inhibitors in <i>KRAS</i> Mutation-positive Non-small-cell Lung Cancer and Sotorasib for <i>KRAS</i> G12C Mutation-positive Non-small-cell Lung Cancer

Authors

Institutions

Publication Details

Journal
Haigan
Published
2025-12-20
DOI
https://doi.org/10.2482/haigan.65.1007
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Analysis of Immune Checkpoint Inhibitors in KRAS Mutation-positive Non-small-cell Lung Cancer and Sotorasib for KRAS G12C Mutation-positive Non-small-cell Lung Cancer

Keita Tagami, Daisuke Morinaga, Akane Mita, Jun Sakakibara et al.
Haigan
Cancer Immunotherapy and Biomarkers
article

An Analysis of Immune Checkpoint Inhibitors in KRAS Mutation-positive Non-small-cell Lung Cancer and Sotorasib for KRAS G12C Mutation-positive Non-small-cell Lung Cancer

Keita Tagami, Daisuke Morinaga, Akane Mita, Jun Sakakibara, H. Takahashi, Yuta Takashima, Tetsuaki Shoji, Masahiro Kashima, S. Konno, Hidenori Kitai
article en

Abstract

No abstract available for this paper.
HaiganVol. 65(7)
Hokkaido University (JP)
Hokkaido University
Openalex Percentile: Top 30%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.